TACE and Clock mechanisms in aging and vascular stiffening
TACE and Clock mechanisms in aging and vascular stiffening
批准号:
10180812
负责人:
Zsolt Bagi
金额:
$44.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-05-31
关键词:
ARNTL geneAgeAgingArteriesBloodBlood VesselsCardiovascular DiseasesCause of DeathCessation of lifeChronologyCircadian DysregulationCircadian RhythmsCollagenComplexDataDevelopmentDilatorDisintegrinsElasticityElastinElderlyEndotheliumEnzymesExhibitsFunctional disorderGene ExpressionGene ProteinsGenesGeneticGenetic TranscriptionGoalsHealthHeart DiseasesHumanHypertrophyIL6 geneImpairmentKnock-outKnockout MiceLifeLinkLongevityMeasuresMediatingMediator of activation proteinMetalloproteasesModelingMolecularMusMyocardial InfarctionOrganOrgan failureOutcomes ResearchOutputPathologicPatientsPeripheralPopulationPreparationProcessPropertyRegulationRelaxationReporterResearchRodentSignal TransductionSleepSpeedStrokeStructural defectTNF geneTestingTimeTransplantationUp-RegulationVariantVascular DiseasesVascular remodelingage effectage relatedagedarterial remodelingarterial stiffnessbaseblood vessel transplantationcircadian pacemakerclinically relevantcostcytokinedisabilityin vivoindexinginsightmanmechanotransductionmouse modelnovelprotein expressionskillstranslational approachvascular abnormality
中文摘要
项目总结
心血管疾病仍然是世界上主要的死亡原因之一。它的进步是
老化过程。从老鼠到人,衰老和心血管疾病的一个始终如一的特征是僵硬
血管的数量。这种弹性特性相当于血管有效地将血液输送到靶器官。
随着进行性僵硬,其后果可能是器官衰竭和死亡,通常是心脏的结果。
攻击和中风,表现出独特的时机,一种昼夜节律。事实上,它的分子组成
昼夜节律-生物钟,包括BMal1、Clock、Per和Cry,我们已经展示了
在血管中的表达和振荡与血管的衰老密切相关。在小鼠身上
对于昼夜节律紊乱的小鼠(BMal1-KO小鼠),我们发现在
他们的血管,这表明时钟坏了可能会加速血管的衰老,并且与年龄有关
病理性血管重塑加重。我们还发现去整合素/金属蛋白酶
ADAM17/TACE独特地跟踪人类血管的年龄,并显示出昼夜节律
其输出包括JAM-1/F11R、肿瘤坏死因子和白介素6R。此外,我们还证明了BMal1-KO小鼠表现出
细胞因子水平增加,产生肿瘤坏死因子和白介素6,在微阵列研究中发现BMal1-KO幼稚和
移植血管的ADAM17靶点有明显变化。这个应用程序的中心假设
生物钟功能障碍是与年龄相关的动脉松弛和功能损害的主要介质
弹性,我们建议通过ADAM17监管。提出了三个具体目标。以特定的目标
我们将确定生物钟失调是否会导致加速的血管功能障碍和动脉
衰老时变得僵硬。在特定的目标2中,我们将剖析动脉壁的内在和外在机制,这是
在衰老过程中改变血管时钟,导致动脉僵硬。在具体目标3中,我们建议研究
年龄依赖性血管硬化中生物钟功能障碍与ADAM17激活的关系。
英文摘要
PROJECT SUMMARY
Cardiovascular disease remains one of the leading causes of death in the world. Its progression is part of the
aging process. From mouse to man, one consistent feature of aging and cardiovascular disease is the stiffening
of blood vessels. This elastic property is tantamount to blood vessels to effectively deliver blood to target organs.
With progressive stiffening, the consequence can be organ failure and death often as a consequence of heart
attacks and strokes, which exhibit a unique timing, a circadian rhythm. Indeed, the molecular components of
circadian rhythm—the circadian clock, including Bmal1, Clock, Per, and Cry, which we have shown are
expressed and oscillating in blood vessels are intimately connected with the aging of blood vessels. In mice
with circadian dysfunction (Bmal1-KO mice), we have discovered that there is increased vascular stiffness in
their blood vessels, suggesting that a broken clock may speed the aging of blood vessels, and age-dependent
worsening of pathological vascular remodeling. We have also found that the disintegrin/metalloprotease
ADAM17/TACE tracks uniquely with age in human blood vessels, and that it exhibits a circadian rhythm as do
its outputs including JAM-1/F11r, TNF, and IL6r. Moreover, we also demonstrate that Bmal1-KO mice exhibit
increased levels of the cytokine outputs TNF and IL6, and in a microarray study find Bmal1-KO naïve and
transplanted vessels exhibit significant changes in ADAM17 targets. The central hypothesis of this application
is that dysfunction of circadian clock is a prime mediator of age-related impairment of arterial relaxation and
elasticity, which we propose is through ADAM17 regulation. Three Specific Aims are proposed. In Specific Aim
1 we will determine if a dysfunctional circadian clock mediates accelerated vascular dysfunction and arterial
stiffening in aging. In Specific Aim 2, we will dissect the arterial wall-intrinsic and extrinsic mechanisms, which
alter vascular clock and cause arterial stiffness in aging. In Specific Aim 3, we propose to examine the
relationship between circadian clock dysfunction and ADAM17 activation in age-dependent vascular stiffening.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.14814/phy2.15643
发表时间:
2023-03
期刊:
Physiological reports
影响因子:
2.5
作者:
[]
通讯作者:
DOI:
10.3389/fnmol.2023.1125932
发表时间:
2023
期刊:
FRONTIERS IN MOLECULAR NEUROSCIENCE
影响因子:
4.8
作者:
[Tian, Yanna, Fopiano, Katie Anne, Buncha, Vadym, Lang, Liwei, Suggs, Hayden A., Wang, Rongrong, Rudic, R. Daniel, Filosa, Jessica A., Bagi, Zsolt]
通讯作者:
Bagi, Zsolt
DOI:
10.1016/j.coph.2021.04.010
发表时间:
2021-08
期刊:
Current opinion in pharmacology
影响因子:
4
作者:
[Han Q, Bagi Z, Rudic RD]
通讯作者:
Rudic RD
DOI:
--
发表时间:
2019-06
期刊:
The Yale Journal of Biology and Medicine
影响因子:
--
作者:
[Yanyan Xu;W. Pi;R. Rudic]
通讯作者:
Yanyan Xu;W. Pi;R. Rudic
Too much TRAFfic at the crossroads of diabetes and endothelial dysfunction.
太多的交通处于糖尿病和内皮功能障碍的十字路口。
DOI:
10.1152/ajpheart.00614.2017
发表时间:
2018
期刊:
American journal of physiology. Heart and circulatory physiology
影响因子:
--
作者:
[Bagi,Zsolt]
通讯作者:
Bagi,Zsolt
共 6 条
TACE and Clock mechanisms in aging and vascular stiffening
-
批准号:9553438
-
项目类别:
-
资助金额:$44.87万
-
财政年份:2017
-
负责人:Zsolt Bagi
-
依托单位:
TACE and Clock mechanisms in aging and vascular stiffening
-
批准号:9219957
-
项目类别:
-
资助金额:$44.87万
-
财政年份:2017
-
负责人:Zsolt Bagi
-
依托单位:
Flow-induced coronary vasospasm in diabetic patients
-
批准号:8478180
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2010
-
负责人:Zsolt Bagi
-
依托单位:
Flow-induced coronary vasospasm in diabetic patients
-
批准号:8397708
-
项目类别:
-
资助金额:$27.1万
-
财政年份:2010
-
负责人:Zsolt Bagi
-
依托单位:
Flow-induced coronary vasospasm in diabetic patients
-
批准号:7948748
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2010
-
负责人:Zsolt Bagi
-
依托单位:
Flow-induced coronary vasospasm in diabetic patients
-
批准号:8286370
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2010
-
负责人:Zsolt Bagi
-
依托单位:
Flow-induced coronary vasospasm in diabetic patients
-
批准号:8125110
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2010
-
负责人:Zsolt Bagi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: